Telomeres Naturally Shorten as We Age


Telomeres are specialized DNA sequences that cap the ends of chromosomes, protecting them from degradation. As cells undergo division, telomeres experience a natural shortening process. This gradual erosion ultimately leads to critically short telomeres, a hallmark of cellular aging that drives cellular senescence (growth arrest) and immune exhaustion.

Chen, Q. & Chen, Y. P. BMC Bioinformatics. 2006. 7(394). DOI: 10.1186/1471-2105-7-394.

Subhead: the breakthrough research

This description is roughly 150 characters and roughly 30+ words. Describe the technology in brief but clear detail. Do not over elaborate.

Subhead: founding research (or milestone) that led to company

This description is roughly 150 characters and roughly 30+ words. Describe the technology in brief but clear detail. Do not over elaborate.

The Fitness of CAR-Engineered Cells Declines During Ex-Vivo Expansion

As cells age, their telomeres naturally shorten, eventually reaching a point where the cells can no longer divide. This cellular aging process is dramatically accelerated in cells that are isolated from the body and carried through the cell therapy manufacturing process for both autologous and allogeneic immunotherapy products.

Telos's mission is to overcome these limitations.

Steinberg, G. R. & Hardie, D. G. Nat. Rev. Mol. Cell Biol. 2022. DOI: 10.1038/s41580-022-00547-x.

Telovance™: The Potential to Improve the Performance of CAR-Engineered Cells

Telovance™ has been shown to safely lengthen telomeres during the ex-vivo expansion phase of cell therapy manufacturing. Telovance™ aims to extend replicative lifespan, improve cytotoxicity, and decrease cell exhaustion.

Li, M., et. al. Mech. Aging. Dev. 2012. 133(11-12). 655-64. DOI: 10.1016/j.mad.2012.09.001.
Mortensen, B., et. al. Am. J. Physiol. Endocrinol. Metab. 2009. 297. E956-64. DOI: 10.1152/ajpendo.00058.2009.

Subhead: the breakthrough research

This description is roughly 150 characters and roughly 30+ words. Describe the technology in brief but clear detail. Do not over elaborate.

Subhead: founding research (or milestone) that led to company

This description is roughly 150 characters and roughly 30+ words. Describe the technology in brief but clear detail. Do not over elaborate.

Telovance™ Has the Potential to Improve the Lifespan and Performance of Any Cell Type

Cell therapies hold promise for treating a wide range of diseases. Our novel platform has the potential to benefit therapies of any cell type by helping ensure that engineered cells expand well and are therapeutically robust.    

Steinberg, G. R. & Hardie, D. G. Nat. Rev. Mol. Cell Biol. 2022. DOI: 10.1038/s41580-022-00547-x.
Steinberg, G. R. & Hardie, D. G. Nat. Rev. Mol. Cell Biol.2022. DOI: 10.1038/s41580-022-00547-x

Founding Research

Research Q&A

Ratione Ut

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur

Aut Debitis Laboriosam Commodi

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

About Cambrian Biopharma

This paragraph is ~100 characters, 30 words, should describe more about Cambrian Biopharma